A B S T R A C T Dermal fibroblasts in culture from a woman with a mild to moderate form of osteogenesis imperfecta synthesize two species of the proa2-chain of type I procollagen. One chain is normal. The abnormal chain has a slightly faster mobility than normal during electrophoresis in sodium dodecyl sulfate polyacrylamide gels. Analysis of cyanogen bromide peptides of the proa-chain, the a-chain, and of the mammalian collagenase cleavage products of the proa-and a-chains indicates that the abnormality is confined to the a2(I)CB4 fragment and is consistent with loss of a short triple-helical segment. Type I collagen production was decreased, perhaps because the molecules that contained the abnormal chain were unstable, with a resultant alteration in the ratio of type III to type I collagen secreted into culture medium. Collagen fibrils in bone and skin had a normal periodicity but their diameters were 50% of control; the bone matrix was undermineralized. The structural abnormality in the a2(I)-chain in this patient may affect molecular stability, intermolecular interactions, and collagenmineral relationships that act to decrease the collagen content of tissues and affect the mineralization of bone.
A B S T R A C T Dermal fibroblasts in culture from a woman with a mild to moderate form of osteogenesis imperfecta synthesize two species of the proa2-chain of type I procollagen. One chain is normal. The abnormal chain has a slightly faster mobility than normal during electrophoresis in sodium dodecyl sulfate polyacrylamide gels. Analysis of cyanogen bromide peptides of the proa-chain, the a-chain, and of the mammalian collagenase cleavage products of the proa-and a-chains indicates that the abnormality is confined to the a2(I)CB4 fragment and is consistent with loss of a short triple-helical segment. Type I collagen production was decreased, perhaps because the molecules that contained the abnormal chain were unstable, with a resultant alteration in the ratio of type III to type I collagen secreted into culture medium. Collagen fibrils in bone and skin had a normal periodicity but their diameters were 50% of control; the bone matrix was undermineralized. The structural abnormality in the a2(I)-chain in this patient may affect molecular stability, intermolecular interactions, and collagenmineral relationships that act to decrease the collagen content of tissues and affect the mineralization of bone. INTRODUCTION Osteogenesis imperfecta (OI)1 is a heterogeneous group of inherited disorders characterized by bone fragility Dr. Byers is an Established Investigator of the American Heart Association; Dr. Rowe is the recipient of a Research Career Development Award (HD 00330). Address all correspondence to Dr. Byers. and other generalized connective tissue abnormalities (1, 2) . These disorders can be classified into at least six groups on the basis of clinical findings, mode of inheritance, and underlying biochemical abnormality (2) (3) (4) . The mildest of these, type I 01, is characterized by osseous fragility that usually decreases at the time of puberty, lack of bone deformity, blue sclerae, and presenile hearing loss. Inheritance is autosomal-dominant and two subtypes can be distinguished on the basis of the presence or absence of dentinogenesis imperfecta. The other varieties are considerably more severe, one leading to death in the newborn period. An additional subtype of intermediate severity, in which there is mild to moderate bone deformity and short stature has been distinguished by some investigators (3, (5) (6) (7) . We have studied the collagens synthesized in culture by dermal fibroblasts from one such patient and have found that some type I procollagen molecules contain an abnormal proa2(I)-chain; this chain appears to interfere with molecular stability, collagen fibril assembly and/or stabilization, and bone mineralization, thus providing a molecular basis for one form of O0. She had a triangular face with frontal bossing and a prominent occipital overhang. Her sclerae were deep blue in color and she had bilateral annulis senilis. The funduscopic examination was normal. The tympanic membranes were of normal color and architecture. Her teeth were in good repair, were not opalescent, and there was no evidence of unusual wear or exposure of dentin. She had a pectus carinatum and mild kyphoscoliosis. Her lungs were clear to percussion and auscultation; axillary hair was absent, and the heart had no murmurs or clicks. No abdominal organomegaly was palpated. She had mild hyperextensibility of the small joints of the hands, pes planus on the right, mild muscle wasting in both the lower extremities, the right more than the left. Surgical scars were present just above the left knee. In her hands and feet the phalanges appeared to be abnormally thin giving prominence to the distal interphalangeal joints. She had a valgus deformity of the toes on the right foot. The left ankle was abnormal in that the distal ends of the tibia and fibula were subluxed over the talus, which was medially and anteriorly displaced. Reflexes were equal bilaterally.
Summary of laboratory studies included: hematocrit, 35.7; serum calcium, 4.8 meg/liter; phosphorus, 2.6 mg/dl; alkaline phosphatase, 57 U/liter (normal = 36-124 U/liter); thyroxine by radioimmunoassay (RIA), 10 .2 (normal = 5.0-12.0); and triiodothyronine by RIA= 212 ng/dl (normal = 122-213 ng/dl). The 24-h urinary excretion of calcium was 4.2 meq and of hydroxyproline was 17 mg (normal = 22-77 mg). Serum parathyroid hormone was 340 ng/ml (normal = 230-630 ng/ml). Radiologic examination of the spine demonstrated reduction in bony density with partial loss of height of multiple dorsal and lumbar vertebrae. The upper lumbar vertebrae were bioconcave and several thoracic vertebral bodies were compressed. There were extensive degenerative changes at the posterial intervertebral joints in the mid-and lower lumbar spine. The right tibia and fibula were slightly bowed and had a coarse texture and porosity. There was depression of both the medial and lateral tibial plateaus. Marked calcification of the right achilles tendon was present. The femurs showed marked cortical thinning with slight bowing on the right. There was an abnormal bony texture and osteopenia apparent on x rays of the hands and degenerative changes that affected several of the small joints.
Audiometric examination disclosed a sharply sloping bilateral hearing loss >900 cpm. Otoadmittance tympanometry revealed a characteristically notched curve at 660 Hz suggestive of increased compliance of the middle ear (8) . (9) . Control cell strains were obtained from individuals aged newborn to 50 yr who had no evidence of connective tissue disorders.
METHODS
Collagen production by cells in culture was measured by a modification of the procedure described by Peterkofsky and Diegelmann (10) . Cells were preincubated in DMEM that contained 5% dialyzed fetal calf serum and 50 ;&g/ml of ascorbic acid and then transferred to the same medium that contained 10 jLCi/ml of [2,3-3H]proline (New England Nuclear, Boston, MA; 25 Ci/mmol). The cells were incubated for 6 h (total collagen synthesis) or 24 h (typing of collagen or procollagen). In either case the medium and cells were separated, placed on ice, and protease inhibitors (phenymethanesulfonyl fluoride, N-ethylmaleimide, and ethylenediamine tetraacetic acid) were added to both to prevent proteolysis (11) . The medium and cell layer were recombined to measure total collagen production and to quantitate production of different collagen types.
To measure the relative ratios of types I and III collagens produced by these cells, combined medium and cell layer proteins' were precipitated with 15% (wt/vol) trichloroacetic acid and then redissolved in 0.5 N acetic acid adjusted to pH 2 with HCL. The solution was incubated with 1 mg/ml of pepsin at 15'C for 2 h after which the reaction was terminated by addition of 50 ug/ml of lathyritic rat skin collagen. Solid NaCl was added to a concentration of 5% (wt/vol) NaCl and the resulting precipitate was collected, washed once with 20% (wt/vol) NaCl, 50 mM Tris pH 7.5, and then with 18% ethanol. The air-dried residue was dissolved in electrophoresis sample buffer without added reducing agent and heated 5 min in boiling water. The al(III)-, al(I)-, and a2(I)-chains were separated on a 7% polyacrylamide slab gel (12) by the technique of interrupted reduction (13) . The radioactive proteins were detected by radioautofluorography (14) and their relative intensities measured by a Transidyne scanning densitometer (model 2955; Transidyne General Corp., Ann Arbor, MI).
The medium procollagens were analyzed on 5% sodium dodecyl sulfate (SDS) acrylamide slab gels as described by Laemmli (12) except that the sample and chamber buffers contained 2 M urea to enhance the separation of proal(I)-from proal(III)-chains. The samples were prepared either by precipitation of the medium proteins with 30% saturated ammonium sulfate followed by two washes with 18% ethanol and air drying or by dialysis of the medium against 1 mM ammonium bicarbonate, 0.1 mM phenylmethanesulfonyl fluoride, and 0.5 mM N-ethylmaleimide followed by Iyophilization.
To label proteins for peptide mapping, 2.5 X 105 cells were plated in 35-mm culture dishes, allowed to attach and spread overnight, and then incubated with [3H]proline at a concentration of 200 uCi/ml in a volume of 0.4 ml of DMEM lacking fetal calf serum but supplemented with 50 sg/ml of ascorbic acid. Medium and cell layer were harvested separately as described (11) to inhibit proteolysis. Dry samples were dissolved in 50 pl of electrophoresis sample buffer, which contained dithiothreitol, and denatured in boiling water for 3 min. Some radiolabeled collagenous proteins from culture medium were dialyzed into 0.5 N acetic acid and subjected to limited proteolysis with pepsin to produce collagen-size molecules. Aliquots of medium taken before and after pepsin digestion were analyzed by slab gel electrophoresis; additional aliquots of both were cleaved with purified fibroblast collagenase (15, 16) , a generous gift from Dr. Eugene Bauer. The proa-chains, a-chains, and fibroblast collagenase cleavage products were separated by electrophoresis in (SDS)-polyacrylamide gels and then digested, in the gels, with cyanogen bromide and the resultant peptides were separated in a second-dimension gel (11, 17) . Collagen a-chains were isolated by preparative disc-gel electrophoresis and cleaved with cyanogen bromides. The peptides were separated by electrophoresis in 12.5% SDS-polyacrylamide gels.
mRNA from confluent cells in four 100-mm dishes was prepared and translated (18) . An aliquot of the translation mixture that contained [3H]proline-labeled preproa-chains was mixed with concentrated sample buffer and applied to a 5% SDS-polyacrylamide slab gel for electrophoresis.
Bone biopsy specimens were obtained either at open biopsy or with a Craig needle (closed biopsy). Specimens were fixed in glutaraldehyde/cacodylate buffer, pH 7.4 for 5 h. Bone was decalcified over 4-5 d at 4°C in 10% EGTA, 0.1 M Tris, pH 7.4. The specimens were then cut into 1-mm pieces, and postfixed with 1% osmium tetroxide in 0.1 M cacodylate buffer at pH 7.4 for 1 h. The specimens were dehydrated in ethanol and embedded in a mixture of Depont and Spurr's epoxy media. Thin (7,090-nM) sections were cut, stained with 2% phosphotungistic acid, pH 4.5, for 1 h, and viewed in a Philips 201 transmission electron microscope (Philips Electronic, Mahwah, NJ). Skin for electron microscopy was prepared and examined as previously described (19) .
RESULTS
The dermal fibroblasts from this patient had normal growth characteristics in culture. About 4.2% of the protein produced by the OI cells was collagenous, which is lower than normal (7.2%, n = 25, P < 0.05). After pepsin digestion of the combined cells and medium proteins, the ratio of al(III) to al(I) was 0.42 (control was 0.19, P < 0.05). Because the production of type III procollagen appeared normal (see below and Fig. 1 ) the decrease in collagen production is accounted for by a decrease in production of type I procollagen.
In the course of measuring the ratio of type I to type III collagen, it was noted that the a2(I)-chains from the 01 cells migrated as a broad band or doublet during electrophoresis (Fig. 1A) . The additional material always migrated more rapidly than normal. The proa2(I)-chain migrated as a broad band, wider than the control (Fig. IB) . The ratio of proal(III) to proal(I) was 0.36 (normal 0.20), whereas the ratio of proal (I) to proa2(I) was 1.8 (within the normal range). mRNA from four confluent 100-mm culture dishes was extracted and the 28 S RNA was translated in a reticulocyte lysate. The collagen mRNA activity for this 01 cell strain, measured by translation, was the same as that of control cells. The migration of the preproa2(I)-chain from the patient's cells was normal and the amount of translatable mRNA for preproal(I) and preproa2(I) was comparable to control (Fig. IC) . These results suggested that the 01 cells produced a population of abnormal proa2(I)-chains that were assembled into molecules normally but which, once in a trimer, produced an unstable type I procollagen. The brother, and one sister were normal and there was no evidence of the abnormal a2(I)-chain. The altered mobility of the proa2(I)-and the a2(I)-chains suggested that they may be missing peptidyl material. To locate the abnormality within the chain, pepsin-treated medium procollagen was cleaved asymmetrically with fibroblast collagenase. Fibroblast collagenase cleaves each chain of type I collagen at a single site three quarters of the length from the NH2-terminal end of the triple helical domain to produce a TCA (tropocollagen) fragment (large) and TCB fragment (small) from each chain. Only the TCA fragment of the affected a2-chain was abnormal (Fig. 2) ; the TCB fragments had normal mobility (Fig. 2) . When the separated proa2(I)-chains, a2(I)-chains and TCA fragments of proa2(I)-and a2(I)-chains were digested with cyanogen bromide, the a2(I)CB4 peptide from each abnormal chain had an altered mobility (Fig. 3) . The difference in mobility was consistent with a change in apparent molecular weight of -2,000, or 15-20 amino acids. The change in mobility of the whole a2(I)-chain thus appeared to be a consequence of an alteration that was limited to the domain of a2(I)CB4 (Fig. 4) .
The alterations in collagen production and structure affected the nature of the extracellular matrix in bone and skin. Bone from the iliac crest was relatively acellular but had a well-preserved lamellar structure and there was less mineral than normal. Collagen in skin was less dense than normal (Fig. 5) . Collagen fibrils in bone and skin (Fig. 5) were smaller in diameter than normal; those in bone were disorganized. These abnormalities of collagen fibril structure and organization in skin demonstrate the generalized nature of the connective tissue defect in osteogenesis imperfecta. A bone biopsy taken 1 yr after estrogen treatment showed an increase in the mean fibril diameter from 58 to 76 nm and enhanced cellularity. The new bone formation on the lamellar surface had a fibrillar appearance with irregular calcification.
DISCUSSION
The collagens are a family of structurally similar proteins with tissue-specific distributions (20) . Type I collagen, the major protein of skin and bone matrix, is synthesized by fibroblasts and osteoblasts (and other cells) as a heteropolymer that contains two genetically distinct chains, al(I) and a2(I) in a 2:1 ratio: [al(I)]2a2(I). The genes for these proteins are among the largest and most complex yet isolated (21) . The 5,000 base pairs (bp) coding sequences (exons) are distributed over -40,000 bp of DNA (22) (23) (24) (25) . The exons that code for sequences in the triple helical domain are small, containing 54-108 bp so that the majority of the gene is made up of intervening sequences (introns). The genes are transcribed in the nucleus to precursor mRNA, colinear with the genes, which are processed to mature mRNA by precise scission of introns (26) . The mRNA is transported to the membranes of the rough endoplasmic reticulum where it is translated by membranebond ribosomes to produce preproa-chains. The preproa- C 01 C 01 FIGURE 3 Autoradiofluorogram of cyanogen bromide cleavage products of proa-chains, achains, and TCA fragments of proa-chains from control and 01 samples. A, proa-chains; B, a-chains, and C, TCA fragments of proa-chains. The radiolabeled proa-chains and TCA fragments were first separated in 5% and 7.5% SDS-polyacrylamide gels, respectively, and then cleaved in the gel with cyanogen bromide as described in Methods. The peptides were then separated in the second dimension on a 12.5% gel. The a-chains, prepared by pepsin digestion of whole medium, were isolated by preparative gel electrophoresis. This technique does not separate the normal and abnormal a2(I)-chains so cleavage products of both are represented in the OI a2(I) slot. The methionine between a2(I)CB3 and a2(I)CB5 does not cleave efficiently with cyanogen bromide and the majority of the protein in these peptides is represented in a2(I)CB3-5. The arrows indicate the altered a2(I)CB4 peptide in each sample. Because the mobility of the a2(I)CB3-5 or its fibroblast collagenase product, a2(I)CB3_5A is normal, neither a2(I)CB3 nor a2(I)CB5 is abnormal in the patient's collagen. The molecular weights of the CNBr peptides are: a2(I)CB3, a2(I)CB4, and a2(I)CB5 all 28,000; a2(I)CB3-5, 56,000; al(I)CB7 and al(I)CB8 both 24,000; al(I)CB6, 16 ,000; and al(I)CB3, 13,000. chains are converted to proa-chains by the loss of the "signal" sequence during transit through the membrane, they are then hydroxylated, glycosylated, and assembled into procollagen molecules which are packaged in the Golgi apparatus, secreted, converted to collagen in the extracellular space, assembled into fibrils, and stabilized by intermolecular crosslinks (see 27, 28 for reviews). Dermal fibroblasts in culture from this patient with a variety of osteogenesis imperfecta synthesize two species of a2(I)-chains. One is normal but the other has an alteration in the structure of the a2(I)CB4 cyanogen bromide peptide. Although it initially appeared that the abnormality in a2(I) migration could be induced by pepsin, analysis of a2(I)CB4 from the proa2(I)-chain, the a2(I)-chain, and the fibroblast collagenase products of these chains indicate that the faster migrating form of the peptide is present in all these molecular species. A short deletion of peptidyl material from within the helical domain of the a2(I)-chain in the a2(I)CB4 sequence is one explanation for the altered electrophoretic mobilities (3, 11) , but we cannot yet exclude the possibility that a single amino acid substitution could alter migration (29) . The difference in molecular weight between the normal and abnormal (1,500-2,000 D) a2(I)CB4 could be accounted for by loss of expression of a single exon (54 bp) that codes for 18 amino acids. The genetic material could be lost or an abnormality in splice junctions Abnormal a2(I) Collagen Chain in Osteogenesis Imperfecta (30) . The ratio of the normal to abnormal a2(I)-chains is greater than one, which suggests that some of the type I procollagen molecules that include the abnormal proa2(I)-chain may be unstable and thus be degraded during processing. This would account for the decreased ratio of type I to III collagen produced by these cells. Because assays of proal(I) and proa2(I) message levels by translation (see Fig. 1 ) and by hybridization with specific probes (unpublished observations) indicate that normal amounts of these messages are present, it is unlikely that this woman has inherited an additional abnormal allele that alters the rate of synthesis of proal(I) such as is seen in some patients with type I 01 (31) . Further characterization of the defect at the level of gene structure will be required to fully understand the precise mechanisms by which a2(I)-chain structure and the production of type I procollagen have been altered in this patient's cells.
The osseous abnormalities in type I 01 are most commonly associated with mild osteoporosis, that is normal mineralization of a decreased amount of organic matrix. In this patient, the histological and ultrastructural studies of bone and skin suggest that there is decreased collagen in the matrix and that there may be defective mineralization. The affected region of the a2(I)-chain, the a2(I)CB4 peptide, appears to have at least two functions. Intermolecular interactions are stabilized in part through crosslinks that involve a lysine or hydroxylysine in a2(I)CB4 (32 There are a number of other patients who have more severe bone disease, one of whom is represented by this patient. These individuals have mild to moderate short stature, moderate bone deformity, and decreased bone mineral density. Bauze et al. (5) and Smith et al. (6) distinguished these patients from those with the mild, "classic" form of type I OI on the basis of clinical findings and by analysis of some physical properties of skin collagen. More detailed studies of collagen synthesized in culture by dermal fibroblasts from other such patients suggests that some individuals in this group may have abnormalities in the production or structure of the proa2(I)-chain (35) . One patient, a child with moderate bone deformity, was recently investigated (36, 37) and cells in culture were found to produce [al(I)]3 but no normal type I procollagen.
Although mRNA for proa2(I) was detectable by a translation assay and proa2(I) was identified intracellularly, there appeared to be little incorporation of the chain into normal type I procollagen molecules (38; Byers, Rowe, Pope, and Nicholls, unpublished observations). Because the parents were consanguineous, the most likely explanation for these findings is that an unstable proa2(I)-chain is produced that does not assemble into type I procollagen molecules. Muller et al. (39) studied a child with moderate deformity and fractures (40) whose cells in culture produced a decreased amount of a2(I) when measured after pepsin digestion of medium procollagens. The molecular details of this disorder were not further explored. We have recently studied an infant whose cells in culture secrete about equal amounts of normal type I procollagen and type I trimer. Whether this is the result of decreased synthesis of proa2(I) or production of a proa2(I) that does not assemble into type I procollagen molecules is not yet clear (Byers, David, and Hunter, unpublished observation). The biochemical, histologic, and clinical findings in these patients suggest that the a2(I)-chain is important for normal bone structure and that some, but not all (41) , alterations in its synthesis and structure may result in abnormal bone mineralization.
The clinical and genetic classification of osteogenesis imperfecta (2) provides a useful guideline for genetic counselling. However, as biochemical studies proceed it is becoming clear that even within clinically defined categories there is considerable biochemical heterogeneity (3). As expected, the initial clinical classification is being revised to accommodate new clinical observations and the results of biochemical studies (3, 42 (3) .
